Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
Authors
Keywords
-
Journal
Frontiers in Public Health
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-07-19
DOI
10.3389/fpubh.2022.917732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China
- (2022) Min Kang et al. ANNALS OF INTERNAL MEDICINE
- Impact of the Sinopharm’s BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE)
- (2022) Farida Ismail AlHosani et al. VACCINE
- Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study
- (2022) Paskorn Sritipsukho et al. Emerging Microbes & Infections
- CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study
- (2022) Enny S. Paixao et al. BMC Medicine
- Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers
- (2022) Alexandre R. Marra et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study
- (2022) Analía Rearte et al. LANCET
- Effectiveness of CoronaVac in children 3 to 5 years during the SARS-CoV-2 Omicron outbreak in Chile
- (2022) Alejandro Jara et al. NATURE MEDICINE
- Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers
- (2022) Gunay Can et al. VACCINE
- Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021
- (2022) Chao Ma et al. VACCINE
- Effectiveness of Coronavirus Disease 2019 Vaccines in Preventing Infection, Hospital Admission, and Death: A Historical Cohort Study Using Iranian Registration Data During Vaccination Program
- (2022) Alireza Mirahmadizadeh et al. Open Forum Infectious Diseases
- Early Effectiveness of Four SARS-CoV-2 Vaccines in Preventing COVID-19 among Adults Aged ≥60 Years in Vojvodina, Serbia
- (2022) Vladimir Petrović et al. Vaccines
- The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization
- (2021) Michele Kohli et al. VACCINE
- Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
- (2021) Jidi Zhao et al. VALUE IN HEALTH
- A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated With Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies
- (2021) Marcus Shaker et al. Journal of Allergy and Clinical Immunology-In Practice
- Simplified Mathematical Modelling of Uncertainty: Cost-Effectiveness of COVID-19 Vaccines in Spain
- (2021) Julio Emilio Marco-Franco et al. Mathematics
- What do we know about China’s covid-19 vaccines?
- (2021) Chris Baraniuk BMJ-British Medical Journal
- COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey
- (2021) Arnold Hagens et al. Vaccines
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and effectiveness of SARS‐CoV‐2 vaccines: A systematic review and meta‐analysis
- (2021) Yunzhi Ling et al. JOURNAL OF MEDICAL VIROLOGY
- Economic evaluation for mass vaccination against COVID-19
- (2021) Wei-Chun Wang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
- (2021) Mine Durusu Tanriover et al. LANCET
- Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
- (2021) Alejandro Jara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis
- (2021) Denny John et al. BMJ Open
- Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
- (2021) Otavio T Ranzani et al. BMJ-British Medical Journal
- Pharmaco Economics Analysis of COVID-19 Vaccines in Ukraine
- (2021) Tsekhmister Yaroslav Volodymyrovych et al. Journal of Pharmaceutical Research International
- The Cost-Effectiveness of a COVID-19 Vaccine in a Danish Context
- (2021) Kristian Debrabant et al. CLINICAL DRUG INVESTIGATION
- Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis
- (2021) Caifang Zheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
- (2021) Gang Zeng et al. LANCET INFECTIOUS DISEASES
- Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
- (2021) Qiao Liu et al. Infectious Diseases of Poverty
- A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
- (2021) Shahad Saif Khandker et al. Vaccines
- The Influence of China’s COVID-19 Treatment Policy on the Sustainability of Its Social Health Insurance System
- (2021) Fei Zuo et al. Risk Management and Healthcare Policy
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- Disease and healthcare burden of COVID-19 in the United States
- (2020) Ian F. Miller et al. NATURE MEDICINE
- The Impact of Novel Coronavirus COVID‐19 on Non‐Communicable Disease Patients and Health Systems: A Review
- (2020) Andrew Y. Chang et al. JOURNAL OF INTERNAL MEDICINE
- Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
- (2018) Cynthia Chen et al. Lancet Global Health
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search